Larvol Delta - Phase-2-Trial-of-Icovamenib-in-Participants-With-Type-2-Diabetes-Who-Are-Not-Achieving-Glycemic-Targets

icovamenib (BMF-219) - Biomea Fusion

http://clinicaltrials.gov/ct2/show/NCT07502495

Apr 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next